The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Market Size Of The Ribonucleic Acid (RNA) Sequencing Market In 2026 And What Value Is Projected For 2030?
The ribonucleic acid (rna) sequencing market has experienced significant expansion in recent years. Its value is anticipated to climb from $3.96 billion in 2025 to $4.84 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 22.3%. This past growth can be attributed to factors such as the proliferation of genomics research initiatives, a decrease in sequencing costs, an increase in academic research funding, wider adoption of next-generation sequencing, and a heightened demand for gene expression analysis.
The ribonucleic acid (rna) sequencing market is poised for significant expansion in the upcoming years. Its valuation is anticipated to climb to $9.63 billion by 2030, driven by a compound annual growth rate (CAGR) of 18.8%. This projected increase is primarily due to the rising acceptance of precision medicine strategies, increased funding in transcriptomics studies, the expansion of clinical diagnostic sequencing capabilities, the growing incorporation of AI-powered data analysis, and an intensified focus on personalized treatments. Dominant trends during the forecast period encompass the wider implementation of single-cell RNA sequencing, increased reliance on high-throughput sequencing technologies, deeper integration of advanced bioinformatics instruments, the broadening scope of clinical and translational research uses, and an elevated commitment to data precision and replicability.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15665&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Ribonucleic Acid (RNA) Sequencing Market?
An escalating emphasis on precision medicine is poised to spur the growth of the ribonucleic acid (RNA) sequencing market moving forward. Precision medicine, also known as personalized medicine, represents an innovative strategy for medical treatment and prevention that accounts for individual variations in genes, environment, and lifestyle. Personalized medicine holds the promise of delivering more effective treatments, driven by advancements in genomics, increasing disease complexity, and regulatory backing. RNA sequencing technologies are instrumental in determining the sequence and quantifying the expression levels of RNA molecules within a sample. This allows for thorough analysis of transcriptomes and provides valuable insights into gene expression patterns, alternative splicing events, and RNA modifications. For instance, in February 2024, as per the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, in contrast to six in 2022. Thus, the increasing focus on precision medicine is a primary driver for the ribonucleic acid (RNA) sequencing market.
What Are The Key Segments Of The Ribonucleic Acid (RNA) Sequencing Market?
The ribonucleic acid (rna) sequencing market covered in this report is segmented –
1) By Product Type: Instruments, Reagents And Kits, Software
2) By Technology: Single Molecule Based Sequencing, Sequence By Synthesis Technology, Nanopore Sequencing Technology, Ion Torrent Semiconductor Sequencing
3) By Applications: Diagnostics, Drug Discovery, Translational Medicine, Other Applications
4) By End User: Research And Academia, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Instruments: Next-Generation Sequencers, Microarray Instruments, Single-Cell Rna Sequencing Instruments
2) By Reagents And Kits: Rna Extraction Kits, Rna Sequencing Kits, Library Preparation Kits
3) By Software: Data Analysis Software, Data Management Software, Bioinformatics Software
What Trends Are Advancing Progress In The Ribonucleic Acid (RNA) Sequencing Market?
Companies operating within the ribonucleic acid (RNA) sequencing market are prioritizing RNA next-generation sequencing assays to enhance patient care through data-driven insights and precision medicine. An RNA next-generation sequencing assay is a next-generation exome sequencing platform that leverages advanced genomic sequencing technologies to analyze a patient’s entire exome. For instance, in June 2023, Tempus, a US-based precision medicine technology company, introduced its new standalone RNA next-generation sequencing assay, Tempus xR. This innovative assay, developed for solid tumors, provides a comprehensive analysis of the entire transcriptome, identifying clinically significant fusions in over 100 targeted genes and altered splicing for MET Exon 14 and EGFRvIII. This offering serves physicians with a specific interest in RNA fusions or altered splicing, alongside providers, researchers, and biopharma companies seeking detailed RNA sequencing analysis of their existing samples.
Who Are The Leading Companies Operating In The Ribonucleic Acid (RNA) Sequencing Market?
Major companies operating in the ribonucleic acid (rna) sequencing market are F Hoffmann La Roche Ltd, Thermo Fisher Scientific Inc, Danaher Corporation, Merck KGaA, Becton Dickinson And Company, Eurofins Scientific SE, Agilent Technologies Inc, Illumina Inc, PerkinElmer Inc, Beckman Coulter Inc, Bio Rad Laboratories Inc, QIAGEN NV, Tecan Genomics Inc, BGI Genomics Co Ltd, Takara Bio Inc, Abcam Limited, Oxford Nanopore Technologies plc, Pacific Biosciences Of California Inc, Macrogen Inc, Standard BioTools Inc, CD Genomics, Genewiz Inc, Novogene Co Ltd, GENEWIZ Germany GmbH, Azenta Life Sciences
Read the full ribonucleic acid (rna) sequencing market report here:
What Are The Leading Geographic Regions In The Ribonucleic Acid (RNA) Sequencing Market?
North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (rna) sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Ribonucleic Acid (RNA) Sequencing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15665&type=smp
Browse Through More Reports Similar to the Global Ribonucleic Acid (RNA) Sequencing Market 2026, By The Business Research Company
Brachioplasty Global Market Report
https://www.thebusinessresearchcompany.com/report/brachioplasty-global-market-report
Cosmetic Surgery Global Market Report
https://www.thebusinessresearchcompany.com/report/cosmetic-surgery-global-market-report
Nasal Splints Global Market Report
https://www.thebusinessresearchcompany.com/report/nasal-splints-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model